B细胞-话题@MedSci

#B细胞#

314篇内容 | 4721人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273240, encodeId=d48212e3240a9, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet oncol：Tazemetostat，EZH2抑制剂，用于B细胞非霍奇金淋巴瘤和晚期固体肿瘤治疗效率良好，且安全性良好, objectType=article, longId=134756, objectId=8eb0134e56d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eb0134e56d7, replyNumber=0, likeNumber=91, createdTime=2018-04-12, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eb0134e56d7, moduleTitle=Lancet oncol：Tazemetostat，EZH2抑制剂，用于B细胞非霍奇金淋巴瘤和晚期固体肿瘤治疗效率良好，且安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eb0134e56d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273239, encodeId=18d012e323982, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：抑制FOXO1活性或许可成为B细胞前体急性淋巴细胞白血病（BCP-ALL）的新的有效疗法, objectType=article, longId=134411, objectId=d0c11344118f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0c11344118f, replyNumber=0, likeNumber=108, createdTime=2018-04-08, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0c11344118f, moduleTitle=Blood：抑制FOXO1活性或许可成为B细胞前体急性淋巴细胞白血病（BCP-ALL）的新的有效疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0c11344118f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273238, encodeId=efec12e3238fe, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：肿瘤抑制信号轴—TGF-β/SMAD1/S1PR2—在弥漫性大B细胞瘤中普遍失活，促进肿瘤细胞增殖, objectType=article, longId=134316, objectId=b8861343160d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8861343160d, replyNumber=0, likeNumber=78, createdTime=2018-04-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8861343160d, moduleTitle=Blood：肿瘤抑制信号轴—TGF-β/SMAD1/S1PR2—在弥漫性大B细胞瘤中普遍失活，促进肿瘤细胞增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8861343160d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273237, encodeId=539612e323716, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, objectType=article, longId=133365, objectId=e4531333650d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4531333650d, replyNumber=0, likeNumber=84, createdTime=2018-03-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4531333650d, moduleTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4531333650d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273236, encodeId=e93612e3236f2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：Pan-SRC激酶抑制剂可阻断非霍奇金淋巴瘤的B细胞受体致瘤信号转导, objectType=article, longId=133361, objectId=5e4b133361e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e4b133361e8, replyNumber=0, likeNumber=117, createdTime=2018-03-26, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e4b133361e8, moduleTitle=Blood：Pan-SRC激酶抑制剂可阻断非霍奇金淋巴瘤的B细胞受体致瘤信号转导, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e4b133361e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273235, encodeId=b1f812e323529, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V2）, objectType=article, longId=133262, objectId=6aec1332625b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aec1332625b, replyNumber=0, likeNumber=43, createdTime=2018-03-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aec1332625b, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aec1332625b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273234, encodeId=20ea12e323441, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：B细胞正常发育需要生理性沉默miR125b的表达, objectType=article, longId=133020, objectId=cca21330202d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cca21330202d, replyNumber=0, likeNumber=65, createdTime=2018-03-22, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cca21330202d, moduleTitle=Blood：B细胞正常发育需要生理性沉默miR125b的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cca21330202d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273233, encodeId=d96e12e3233c8, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：乙肝病毒感染可增加B细胞淋巴瘤患病风险，并可恶化其预后, objectType=article, longId=132937, objectId=93bd13293e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93bd13293e2c, replyNumber=0, likeNumber=96, createdTime=2018-03-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93bd13293e2c, moduleTitle=Blood：乙肝病毒感染可增加B细胞淋巴瘤患病风险，并可恶化其预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93bd13293e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273232, encodeId=affa12e323215, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=CLIN CANCER RES：BAFF受体抗体治疗耐药性B细胞恶性肿瘤, objectType=article, longId=131828, objectId=5b4e13182871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b4e13182871, replyNumber=0, likeNumber=53, createdTime=2018-03-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b4e13182871, moduleTitle=CLIN CANCER RES：BAFF受体抗体治疗耐药性B细胞恶性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b4e13182871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273231, encodeId=f29912e323102, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=CLIN CANCER RES：靶向PI3Kδ治疗成熟B细胞恶性肿瘤, objectType=article, longId=131821, objectId=01dc131821b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01dc131821b8, replyNumber=0, likeNumber=57, createdTime=2018-03-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01dc131821b8, moduleTitle=CLIN CANCER RES：靶向PI3Kδ治疗成熟B细胞恶性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01dc131821b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273230, encodeId=2bf212e323082, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：BTKCys481Ser突变通过再激活ERK1/2驱动恶性B细胞产生依鲁替尼耐药性，并通过旁分泌对未突变细胞产生保护作用, objectType=article, longId=131375, objectId=baed1313e5b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=baed1313e5b2, replyNumber=0, likeNumber=56, createdTime=2018-03-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=baed1313e5b2, moduleTitle=Blood：BTKCys481Ser突变通过再激活ERK1/2驱动恶性B细胞产生依鲁替尼耐药性，并通过旁分泌对未突变细胞产生保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baed1313e5b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273229, encodeId=278112e3229d5, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, objectType=article, longId=130819, objectId=73341308194e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341308194e, replyNumber=0, likeNumber=43, createdTime=2018-03-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341308194e, moduleTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73341308194e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273228, encodeId=772412e3228ed, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路, objectType=article, longId=130399, objectId=be3a13039929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be3a13039929, replyNumber=0, likeNumber=69, createdTime=2018-02-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be3a13039929, moduleTitle=Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be3a13039929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273227, encodeId=0cde12e3227dd, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, objectType=article, longId=129689, objectId=eb3012968908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb3012968908, replyNumber=0, likeNumber=45, createdTime=2018-02-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb3012968908, moduleTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb3012968908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273226, encodeId=d26d12e3226ae, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：P4HA2通过羟基化Carbin促进B细胞淋巴瘤进展, objectType=article, longId=128882, objectId=ad02128882e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad02128882e3, replyNumber=0, likeNumber=73, createdTime=2018-02-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad02128882e3, moduleTitle=Blood：P4HA2通过羟基化Carbin促进B细胞淋巴瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad02128882e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273225, encodeId=e83712e3225d4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）, objectType=article, longId=128660, objectId=42e21286605a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e21286605a, replyNumber=0, likeNumber=43, createdTime=2018-02-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e21286605a, moduleTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42e21286605a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273224, encodeId=ad4312e322409, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, objectType=article, longId=128600, objectId=c14a1286000a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14a1286000a, replyNumber=0, likeNumber=59, createdTime=2018-02-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14a1286000a, moduleTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14a1286000a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273223, encodeId=592e12e322319, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, objectType=article, longId=128476, objectId=1e4c1284e6be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4c1284e6be, replyNumber=0, likeNumber=55, createdTime=2018-02-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4c1284e6be, moduleTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4c1284e6be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273222, encodeId=25af12e3222e3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Cell：天然杀手T细胞在启动B细胞抗病毒免疫反应中的作用, objectType=article, longId=128139, objectId=c2c0128139f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2c0128139f9, replyNumber=0, likeNumber=62, createdTime=2018-01-31, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2c0128139f9, moduleTitle=Cell：天然杀手T细胞在启动B细胞抗病毒免疫反应中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2c0128139f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273221, encodeId=021912e322133, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Duvelisib与免疫检查点抑制剂在B细胞淋巴瘤模型中具有显著协同作用, objectType=article, longId=128118, objectId=6f21128118f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f21128118f9, replyNumber=0, likeNumber=80, createdTime=2018-01-31, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f21128118f9, moduleTitle=Duvelisib与免疫检查点抑制剂在B细胞淋巴瘤模型中具有显著协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f21128118f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet oncol：Tazemetostat，EZH2抑制剂，用于B细胞非霍奇金淋巴瘤和晚期固体肿瘤治疗效率良好，且安全性良好

2018-04-12

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：抑制FOXO1活性或许可成为B细胞前体急性淋巴细胞白血病（BCP-ALL）的新的有效疗法

2018-04-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：肿瘤抑制信号轴—TGF-β/SMAD1/S1PR2—在弥漫性大B细胞瘤中普遍失活，促进肿瘤细胞增殖

2018-04-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药

2018-03-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：Pan-SRC激酶抑制剂可阻断非霍奇金淋巴瘤的B细胞受体致瘤信号转导

2018-03-26

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2018.V2）

2018-03-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：B细胞正常发育需要生理性沉默miR125b的表达

2018-03-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：乙肝病毒感染可增加B细胞淋巴瘤患病风险，并可恶化其预后

2018-03-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

CLIN CANCER RES：BAFF受体抗体治疗耐药性B细胞恶性肿瘤

2018-03-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

CLIN CANCER RES：靶向PI3Kδ治疗成熟B细胞恶性肿瘤

2018-03-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：BTKCys481Ser突变通过再激活ERK1/2驱动恶性B细胞产生依鲁替尼耐药性，并通过旁分泌对未突变细胞产生保护作用

2018-03-05

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？

2018-03-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：原发性纵膈大B细胞淋巴瘤的体细胞IL4R突变，激活JAK-STAT信号通路

2018-02-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用

2018-02-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：P4HA2通过羟基化Carbin促进B细胞淋巴瘤进展

2018-02-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）

2018-02-04

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果

2018-02-04

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病

2018-02-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Cell：天然杀手T细胞在启动B细胞抗病毒免疫反应中的作用

2018-01-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Duvelisib与免疫检查点抑制剂在B细胞淋巴瘤模型中具有显著协同作用

2018-01-31

科室
- - 订阅+
  - 更多科室
工具
服务